Press Releases | BioSenic

BioSenic appoints Dr Carole Nicco as Chief Scientific Officer

Read more about BioSenic appoints Dr Carole Nicco as Chief Scientific Officer

Information relative au nombre total de droits de vote et d’actions

Read more about Information relative au nombre total de droits de vote et d’actions

Information on the total number of voting rights and shares

Read more about Information on the total number of voting rights and shares

BioSenic appoints Michel Wurm, M.D. as Chief Medical Officer

Read more about BioSenic appoints Michel Wurm, M.D. as Chief Medical Officer

Information on the total number of voting rights and shares

Read more about Information on the total number of voting rights and shares

Transparency notifications received from François Rieger, Véronique Pomi, Capital Grand Est, FA DIESE 3 and CPH Banque

Read more about Transparency notifications received from François Rieger, Véronique Pomi, Capital Grand Est, FA DIESE 3 and CPH Banque

BioSenic provides update on its autoimmune disease platform based on ATO (arsenic trioxide)

Read more about BioSenic provides update on its autoimmune disease platform based on ATO (arsenic trioxide)

Transparency notification received from S.R.I.W. SA and Sofipôle SA

Read more about Transparency notification received from S.R.I.W. SA and Sofipôle SA

Information on the total number of voting rights and shares

Read more about Information on the total number of voting rights and shares

Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation

Read more about Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation

Subscribe to Press Releases